Soumit Roy
Stock Analyst at Jones Trading
(1.54)
# 3,292
Out of 4,931 analysts
42
Total ratings
18.75%
Success rate
-5.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.11 | +575.24% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $19.11 | +109.31% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $18.84 | +43.31% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.27 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.93 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $1.78 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.69 | +54.80% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.35 | +325.53% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $18.30 | +85.79% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $36 | $2.10 | +1,614.29% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.05 | +1,460.98% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.87 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $9.37 | -3.95% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $9.88 | +72.06% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.53 | +413.83% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.70 | +470.69% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.34 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.61 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.90 | +229.11% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $24.18 | +189.50% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $40.65 | -75.40% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.59 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $11.09 | +621.70% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.73 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $4.52 | +6,979.65% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.81 | +16,739.92% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.11
Upside: +575.24%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $19.11
Upside: +109.31%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $18.84
Upside: +43.31%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.27
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.93
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.78
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.69
Upside: +54.80%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.35
Upside: +325.53%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $18.30
Upside: +85.79%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.10
Upside: +1,614.29%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.05
Upside: +1,460.98%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.87
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $9.37
Upside: -3.95%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $9.88
Upside: +72.06%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.53
Upside: +413.83%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.70
Upside: +470.69%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.34
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.61
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.90
Upside: +229.11%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $24.18
Upside: +189.50%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $40.65
Upside: -75.40%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.59
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $11.09
Upside: +621.70%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.73
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $4.52
Upside: +6,979.65%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.81
Upside: +16,739.92%